Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

VEGF in Patients with Non-small Cell Lung Cancer during Combination Chemotherapy of Carboplatin and Paclitaxel

MASATO SHINGYOJI, SOICHIRO ANDO, HIROKI NISHIMURA, TAKAHIRO NAKAJIMA, AKI ISHIKAWA, MEIJI ITAKURA, TOSHIHIKO IIZASA and HIDEKI KIMURA
Anticancer Research July 2009, 29 (7) 2635-2639;
MASATO SHINGYOJI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mshingyoji{at}chiba-cc.jp
SOICHIRO ANDO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROKI NISHIMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAHIRO NAKAJIMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKI ISHIKAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MEIJI ITAKURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIHIKO IIZASA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEKI KIMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 7 2635-2639
PMID 
19596939

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 11, 2009
  • Revision received April 27, 2009
  • Accepted May 6, 2009
  • Published online July 13, 2009.

Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MASATO SHINGYOJI,
  2. SOICHIRO ANDO,
  3. HIROKI NISHIMURA,
  4. TAKAHIRO NAKAJIMA,
  5. AKI ISHIKAWA,
  6. MEIJI ITAKURA,
  7. TOSHIHIKO IIZASA and
  8. HIDEKI KIMURA
  1. Department of Thoracic Disease, Chiba Cancer Center, Chiba, Japan
  1. Correspondence to: Masato Shingyoji, Department of Thoracic Disease, Chiba Cancer Center, 666-2, Nitona-cho, Chuo-ku, Chiba, 260-8717 Japan. Tel: +81 432645431, Fax: +81 432659515, e-mail: mshingyoji{at}chiba-cc.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 7
July 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
VEGF in Patients with Non-small Cell Lung Cancer during Combination Chemotherapy of Carboplatin and Paclitaxel
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
VEGF in Patients with Non-small Cell Lung Cancer during Combination Chemotherapy of Carboplatin and Paclitaxel
MASATO SHINGYOJI, SOICHIRO ANDO, HIROKI NISHIMURA, TAKAHIRO NAKAJIMA, AKI ISHIKAWA, MEIJI ITAKURA, TOSHIHIKO IIZASA, HIDEKI KIMURA
Anticancer Research Jul 2009, 29 (7) 2635-2639;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
VEGF in Patients with Non-small Cell Lung Cancer during Combination Chemotherapy of Carboplatin and Paclitaxel
MASATO SHINGYOJI, SOICHIRO ANDO, HIROKI NISHIMURA, TAKAHIRO NAKAJIMA, AKI ISHIKAWA, MEIJI ITAKURA, TOSHIHIKO IIZASA, HIDEKI KIMURA
Anticancer Research Jul 2009, 29 (7) 2635-2639;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors
  • Google Scholar

More in this TOC Section

  • A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to Outcomes
  • Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer
  • Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire